Posted by Michael Wonder on 07 Feb 2018
Canadian generic drug prices higher than international levels in recent years
6 February 2018 - The Patented Medicine Prices Review Board releases its latest report on generic drug pricing in Canada.
The Patented Medicine Prices Review Board, through the National Prescription Drug Utilization Information System research initiative, today published the most recent edition of the Generics360 report, which examines the latest trends in domestic and international generic drug pricing, sales and utilization.
The report found that Canada has a strong generics market with the third highest rate of generic drug use and the second highest per capita spending on generics among OECD countries in 2016.
